Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irregular Heart Rate”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableStudy completedNCT01701817
What this trial is testing

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

Who this might be right for
Atrial Fibrillation
Janssen Scientific Affairs, LLC 13,769
Post-approval studies (Phase 4)Enrolling By InvitationNCT06635863
What this trial is testing

Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat

Who this might be right for
Ventricular ArrythmiaNon-ischemic CardiomyopathyArrhythmogenic Inflammatory Cardiomyopathy
Roderick Tung 40
Large-scale testing (Phase 3)Study completedNCT01729871
What this trial is testing

A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy

Who this might be right for
Atrial Fibrillation
Janssen Scientific Affairs, LLC 253
Post-approval studies (Phase 4)Not Yet RecruitingNCT07706075
What this trial is testing

Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation With Rapid Ventricular Response
Muhammad Ali Javed 120
Large-scale testing (Phase 3)Study completedNCT01830543
What this trial is testing

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Who this might be right for
Atrial FibrillationPercutaneous Coronary Intervention
Janssen Scientific Affairs, LLC 2,124
Not applicableStudy completedNCT04183270
What this trial is testing

Survey on Belgian Patients Suffering From Irregular Heartbeat and Starting Treatment With a Drug to Prevent Blood Clots in Blood Vessels and the Heart. This Study is Also Called BELANCOS.

Who this might be right for
Atrial Fibrillation
Bayer 164
Not applicableStudy completedNCT01165710
What this trial is testing

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Who this might be right for
Atrial Fibrillation
Janssen Scientific Affairs, LLC 10,179
Not applicableEnded earlyNCT05489445
What this trial is testing

All Inclusive Kodex - EPD Study

Who this might be right for
Atrial Fibrillation
University of Arizona 15
Not applicableEnrolling By InvitationNCT06988202
What this trial is testing

Comparative Effectiveness of Different Techniques for Repeat Ablation of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
University of Rochester 630
Not applicableStudy completedNCT00165932
What this trial is testing

Ventricular Synchrony in Pediatric Patients

Who this might be right for
Irregular Heart Rate
Emory University 145
Not applicableStudy completedNCT05295056
What this trial is testing

Clinical Performance of the AFGen1 Device Over a 7-day Period

Who this might be right for
Atrial FibrillationAfibIrregular Heart Beat+4 more
TriVirum, Inc. 38
Not applicableEnded earlyNCT01683045
What this trial is testing

Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats

Who this might be right for
Persistent Atrial Fibrillation
Endoscopic Technologies, Inc 6
Testing effectiveness (Phase 2)Study completedNCT04218266
What this trial is testing

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

Who this might be right for
Atrial Fibrillation (AF)
Bayer 755
Not applicableStudy completedNCT07223164
What this trial is testing

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease

Who this might be right for
Healthy
Masimo Corporation 102
Not applicableStudy completedNCT03847181
What this trial is testing

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Who this might be right for
Atrial Fibrillation
Bayer 45,164
Not applicableStudy completedNCT04356989
What this trial is testing

Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 493